cyclophosphamide prolongs progression-free survival in high-risk CLL Frontline low-dose alemtuzumab with fludarabine

Oers, Abrahamse-Testroote,Jeanette Doorduijn,Wendimagegn Ghidey Alemayehu,Marinus H. J. van, Remes,Eva Kimby,Tomas Kozak,Aaron Polliack,Ka Lung Wu,Shulamiet Wittebol, J. MartineC.,Christian H. Geisler,Mars B. van t'Veer,Jesper Jurlander,Jan Walewski,Geir Tjønnfjord,Maija Itälä

semanticscholar（2014）

引用 28|浏览2

暂无评分

摘要

Oers Abrahamse-Testroote, Jeanette Doorduijn, Wendimagegn Ghidey Alemayehu and Marinus H. J. van Remes, Eva Kimby, Tomas Kozak, Aaron Polliack, Ka Lung Wu, Shulamiet Wittebol, Martine C. J. Christian H. Geisler, Mars B. van t' Veer, Jesper Jurlander, Jan Walewski, Geir Tjønnfjord, Maija Itälä cyclophosphamide prolongs progression-free survival in high-risk CLL Frontline low-dose alemtuzumab with fludarabine and

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要